US Stock MarketDetailed Quotes

LFCR Lifecore Biomedical

Watchlist
  • 7.460
  • -0.170-2.23%
Trading Dec 3 14:32 ET
274.73MMarket Cap53.29P/E (TTM)

Lifecore Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Aug 25, 2024
(FY)May 26, 2024
(Q4)May 26, 2024
(Q3)Feb 25, 2024
(Q2)Nov 26, 2023
(Q1)Aug 27, 2023
(FY)May 28, 2023
(Q4)May 28, 2023
(Q3)Feb 26, 2023
(Q2)Nov 27, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
92.28%-643K
98.76%-217K
481.96%8.64M
86.92%-1.53M
142.75%1.01M
-656.49%-8.33M
22.80%-17.44M
-312.77%-2.26M
33.90%-11.73M
54.20%-2.35M
Net income from continuing operations
-50.92%-16.23M
112.07%12.01M
81.97%-7.08M
142.82%15.63M
211.03%14.22M
1.93%-10.75M
14.70%-99.56M
29.34%-39.28M
-176.61%-36.51M
66.69%-12.81M
Operating gains losses
-350.00%-900K
-192.57%-39.48M
-90.04%2.4M
-201.74%-21M
-94,104.55%-20.68M
90.51%-200K
651.86%42.65M
9,424.90%24.1M
275.97%20.64M
266.67%22K
Depreciation and amortization
-8.07%1.99M
-32.77%8.86M
-15.66%2.25M
-30.50%2.23M
-24.97%2.21M
-50.21%2.17M
-27.04%13.18M
-25.27%2.67M
-8.95%3.21M
-50.21%2.94M
Deferred tax
-231.58%-100K
-54.34%163K
-121.33%-64K
172.86%191K
-1,100.00%-40K
547.06%76K
105.23%357K
122.16%300K
113.78%70K
100.14%4K
Other non cash items
55.85%4.72M
1,360.34%15.61M
540.70%6.2M
21,613.33%3.26M
2,903.85%3.12M
16,922.22%3.03M
350.94%1.07M
749.12%968K
103.50%15K
353.66%104K
Change In working capital
277.74%7.47M
-119.43%-3.85M
-36.84%4.55M
-746.22%-4.78M
-88.22%586K
-161.16%-4.2M
738.21%19.79M
26.22%7.21M
105.67%740K
289.89%4.98M
-Change in receivables
152.26%6.02M
-122.10%-2.39M
-94.36%106K
63.67%-1.29M
-168.60%-3.6M
-67.04%2.39M
276.34%10.82M
35.62%1.88M
70.66%-3.54M
251.77%5.25M
-Change in inventory
-95.88%-1.66M
105.82%862K
-958.33%-309K
133.69%1.78M
102.01%244K
-132.82%-849K
-579.40%-14.81M
-99.63%36K
-146.31%-5.27M
-21.41%-12.16M
-Change in prepaid assets
89.94%-244K
----
----
73.46%-155K
29,664.29%4.17M
-228.28%-2.43M
----
----
-273.81%-584K
-98.47%14K
-Change in payables and accrued expense
195.54%3.66M
-129.05%-4.52M
115.29%376K
-65.10%2.85M
-132.69%-3.91M
-82.34%-3.83M
162.42%15.55M
55.18%-2.46M
4,214.81%8.16M
19.55%11.95M
-Change in other current assets
----
10.39%2.38M
----
----
----
----
412.92%2.16M
----
----
----
-Change in other current liabilities
145.61%1.15M
----
----
----
----
---2.53M
----
----
----
----
-Change in other working capital
-147.85%-1.46M
-102.95%-179K
-16.32%3.59M
-502.17%-7.96M
1,697.22%1.15M
2,728.45%3.05M
33,855.56%6.08M
730.00%4.28M
213.29%1.98M
-28.57%-72K
Cash from discontinued investing activities
Operating cash flow
92.28%-643K
98.76%-217K
481.96%8.64M
86.92%-1.53M
142.75%1.01M
-656.49%-8.33M
22.80%-17.44M
-312.77%-2.26M
33.90%-11.73M
54.20%-2.35M
Investing cash flow
Cash flow from continuing investing activities
32.88%-3.39M
-272.50%-17.92M
57.25%-2.64M
-215.10%-6.25M
-3.40%-3.98M
-2,136.28%-5.05M
-106.02%-4.81M
67.20%-6.17M
-91.72%5.43M
24.50%-3.85M
Net PPE purchase and sale
32.88%-3.39M
16.58%-17.92M
63.24%-2.64M
11.96%-6.25M
-3.40%-3.98M
-50.37%-5.05M
25.41%-21.48M
36.84%-7.17M
-28.74%-7.1M
24.50%-3.85M
Net business purchase and sale
----
--0
--0
--0
----
----
-77.32%16.67M
102.23%1.01M
-89.43%12.53M
--0
Net investment purchase and sale
----
--0
----
----
----
----
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
32.88%-3.39M
-272.50%-17.92M
57.25%-2.64M
-215.10%-6.25M
-3.40%-3.98M
-2,136.28%-5.05M
-106.02%-4.81M
67.20%-6.17M
-91.72%5.43M
24.50%-3.85M
Financing cash flow
Cash flow from continuing financing activities
-62.75%1.09M
-81.09%7.51M
-102.50%-614K
216.36%7.64M
-127.79%-2.45M
-24.88%2.93M
169.62%39.7M
28.36%24.57M
105.13%2.41M
-10.82%8.81M
Net issuance payments of debt
-25.45%1.68M
-11.96%2.75M
-99.54%125K
108.83%2.8M
-161.66%-2.44M
-43.24%2.26M
105.63%3.12M
34.32%26.95M
32.51%-31.76M
-60.34%3.95M
Net common stock issuance
----
--0
----
----
----
----
--4.82M
----
----
----
Net preferred stock issuance
----
--0
--0
----
----
----
--38.08M
--0
----
----
Proceeds from stock option exercised by employees
-99.86%1K
--724K
--0
----
----
--724K
--0
---4.82M
----
----
Net other financing activities
-1,208.89%-589K
163.85%4.04M
68.96%-739K
229.46%4.83M
91.55%-12K
32.84%-45K
-292.80%-6.32M
-157.96%-2.38M
-8,583.72%-3.73M
-69.05%-142K
Cash from discontinued financing activities
Financing cash flow
-62.75%1.09M
-81.09%7.51M
-102.50%-614K
216.36%7.64M
-127.79%-2.45M
-24.88%2.93M
169.62%39.7M
28.36%24.57M
105.13%2.41M
-10.82%8.81M
Net cash flow
Beginning cash position
-55.68%8.46M
1,061.96%19.09M
4.17%3.07M
-52.84%3.22M
104.69%8.64M
1,061.96%19.09M
26.87%1.64M
59.12%2.95M
526.03%6.83M
191.78%4.22M
Current changes in cash
71.84%-2.94M
-160.92%-10.63M
-66.61%5.39M
96.19%-148K
-307.86%-5.42M
-505.16%-10.45M
4,913.79%17.45M
7,749.76%16.14M
-608.52%-3.88M
832.58%2.61M
End cash Position
-36.13%5.52M
-55.68%8.46M
-55.68%8.46M
4.17%3.07M
-52.84%3.22M
104.69%8.64M
1,061.96%19.09M
1,061.96%19.09M
59.12%2.95M
526.03%6.83M
Free cash flow
69.85%-4.04M
53.40%-18.14M
163.62%6M
58.65%-7.79M
52.06%-2.97M
-199.93%-13.38M
25.91%-38.92M
21.04%-9.44M
19.09%-18.83M
39.41%-6.2M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q1)Aug 25, 2024(FY)May 26, 2024(Q4)May 26, 2024(Q3)Feb 25, 2024(Q2)Nov 26, 2023(Q1)Aug 27, 2023(FY)May 28, 2023(Q4)May 28, 2023(Q3)Feb 26, 2023(Q2)Nov 27, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 92.28%-643K98.76%-217K481.96%8.64M86.92%-1.53M142.75%1.01M-656.49%-8.33M22.80%-17.44M-312.77%-2.26M33.90%-11.73M54.20%-2.35M
Net income from continuing operations -50.92%-16.23M112.07%12.01M81.97%-7.08M142.82%15.63M211.03%14.22M1.93%-10.75M14.70%-99.56M29.34%-39.28M-176.61%-36.51M66.69%-12.81M
Operating gains losses -350.00%-900K-192.57%-39.48M-90.04%2.4M-201.74%-21M-94,104.55%-20.68M90.51%-200K651.86%42.65M9,424.90%24.1M275.97%20.64M266.67%22K
Depreciation and amortization -8.07%1.99M-32.77%8.86M-15.66%2.25M-30.50%2.23M-24.97%2.21M-50.21%2.17M-27.04%13.18M-25.27%2.67M-8.95%3.21M-50.21%2.94M
Deferred tax -231.58%-100K-54.34%163K-121.33%-64K172.86%191K-1,100.00%-40K547.06%76K105.23%357K122.16%300K113.78%70K100.14%4K
Other non cash items 55.85%4.72M1,360.34%15.61M540.70%6.2M21,613.33%3.26M2,903.85%3.12M16,922.22%3.03M350.94%1.07M749.12%968K103.50%15K353.66%104K
Change In working capital 277.74%7.47M-119.43%-3.85M-36.84%4.55M-746.22%-4.78M-88.22%586K-161.16%-4.2M738.21%19.79M26.22%7.21M105.67%740K289.89%4.98M
-Change in receivables 152.26%6.02M-122.10%-2.39M-94.36%106K63.67%-1.29M-168.60%-3.6M-67.04%2.39M276.34%10.82M35.62%1.88M70.66%-3.54M251.77%5.25M
-Change in inventory -95.88%-1.66M105.82%862K-958.33%-309K133.69%1.78M102.01%244K-132.82%-849K-579.40%-14.81M-99.63%36K-146.31%-5.27M-21.41%-12.16M
-Change in prepaid assets 89.94%-244K--------73.46%-155K29,664.29%4.17M-228.28%-2.43M---------273.81%-584K-98.47%14K
-Change in payables and accrued expense 195.54%3.66M-129.05%-4.52M115.29%376K-65.10%2.85M-132.69%-3.91M-82.34%-3.83M162.42%15.55M55.18%-2.46M4,214.81%8.16M19.55%11.95M
-Change in other current assets ----10.39%2.38M----------------412.92%2.16M------------
-Change in other current liabilities 145.61%1.15M-------------------2.53M----------------
-Change in other working capital -147.85%-1.46M-102.95%-179K-16.32%3.59M-502.17%-7.96M1,697.22%1.15M2,728.45%3.05M33,855.56%6.08M730.00%4.28M213.29%1.98M-28.57%-72K
Cash from discontinued investing activities
Operating cash flow 92.28%-643K98.76%-217K481.96%8.64M86.92%-1.53M142.75%1.01M-656.49%-8.33M22.80%-17.44M-312.77%-2.26M33.90%-11.73M54.20%-2.35M
Investing cash flow
Cash flow from continuing investing activities 32.88%-3.39M-272.50%-17.92M57.25%-2.64M-215.10%-6.25M-3.40%-3.98M-2,136.28%-5.05M-106.02%-4.81M67.20%-6.17M-91.72%5.43M24.50%-3.85M
Net PPE purchase and sale 32.88%-3.39M16.58%-17.92M63.24%-2.64M11.96%-6.25M-3.40%-3.98M-50.37%-5.05M25.41%-21.48M36.84%-7.17M-28.74%-7.1M24.50%-3.85M
Net business purchase and sale ------0--0--0---------77.32%16.67M102.23%1.01M-89.43%12.53M--0
Net investment purchase and sale ------0------------------0------------
Cash from discontinued investing activities
Investing cash flow 32.88%-3.39M-272.50%-17.92M57.25%-2.64M-215.10%-6.25M-3.40%-3.98M-2,136.28%-5.05M-106.02%-4.81M67.20%-6.17M-91.72%5.43M24.50%-3.85M
Financing cash flow
Cash flow from continuing financing activities -62.75%1.09M-81.09%7.51M-102.50%-614K216.36%7.64M-127.79%-2.45M-24.88%2.93M169.62%39.7M28.36%24.57M105.13%2.41M-10.82%8.81M
Net issuance payments of debt -25.45%1.68M-11.96%2.75M-99.54%125K108.83%2.8M-161.66%-2.44M-43.24%2.26M105.63%3.12M34.32%26.95M32.51%-31.76M-60.34%3.95M
Net common stock issuance ------0------------------4.82M------------
Net preferred stock issuance ------0--0--------------38.08M--0--------
Proceeds from stock option exercised by employees -99.86%1K--724K--0----------724K--0---4.82M--------
Net other financing activities -1,208.89%-589K163.85%4.04M68.96%-739K229.46%4.83M91.55%-12K32.84%-45K-292.80%-6.32M-157.96%-2.38M-8,583.72%-3.73M-69.05%-142K
Cash from discontinued financing activities
Financing cash flow -62.75%1.09M-81.09%7.51M-102.50%-614K216.36%7.64M-127.79%-2.45M-24.88%2.93M169.62%39.7M28.36%24.57M105.13%2.41M-10.82%8.81M
Net cash flow
Beginning cash position -55.68%8.46M1,061.96%19.09M4.17%3.07M-52.84%3.22M104.69%8.64M1,061.96%19.09M26.87%1.64M59.12%2.95M526.03%6.83M191.78%4.22M
Current changes in cash 71.84%-2.94M-160.92%-10.63M-66.61%5.39M96.19%-148K-307.86%-5.42M-505.16%-10.45M4,913.79%17.45M7,749.76%16.14M-608.52%-3.88M832.58%2.61M
End cash Position -36.13%5.52M-55.68%8.46M-55.68%8.46M4.17%3.07M-52.84%3.22M104.69%8.64M1,061.96%19.09M1,061.96%19.09M59.12%2.95M526.03%6.83M
Free cash flow 69.85%-4.04M53.40%-18.14M163.62%6M58.65%-7.79M52.06%-2.97M-199.93%-13.38M25.91%-38.92M21.04%-9.44M19.09%-18.83M39.41%-6.2M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Meta Platforms
META
+2.61%
Coinbase
COIN
+2.13%
Apple
AAPL
+1.07%
Amazon
AMZN
+0.99%
Ecopetrol
EC
+0.57%

Unlock the Full List